ClearPoint Neuro, Inc.

NASDAQ:CLPT

Medical - Devices

Healthcare
$7.71 +5.30%

+$0.89 today

Market cap
$247.14M
Beta
1.31
P/E (TTM)
-18.0
EPS (TTM)
-$0.98
52W Low $8.27High $30.10

Volume 0.64M

Average 0.67M

CLPT Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

ClearPoint Neuro, Inc.NASDAQ: CLPT

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables dips below year-ago levels

Q1 FY2026 accounts payables of $437K (cash outflow) fell 84.8% year over year, behind the +897.9% change in trailing-twelve-month accounts payables. Sequentially, it fell 93.0% from the prior quarter.

Context

  • Accounts payables amounted to 20.3% of revenue in FY2025, up 10.4 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -84.8% toward the trailing-twelve-month pace of +897.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$437K-93.0% QoQ
Last fiscal yearDec 2025
-$7.52M-342.2% YoY
LTMMar 2026
-$5.77M+897.9% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-84.8%——
1 year-342.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
(7.52M) USD
Year-over-year change
-342.2%

Accounts Payables vs competitors

How CLPT compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +897.9% is the 2nd highest of 9, against a peer median of +34.5%.
  • Accounts payables amounts to 14.2% of revenue for CLPT, versus a peer median of 0.7%.
CLPT Competitors
Accounts Payables for CLPT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VREXVarex Imaging CorporationLTM Apr 2026$22.9M USD+1661.5%-32.0%2.7%
OFIXOrthofix Medical Inc.LTM Mar 2026$19.16M USD+164.5%+4.4%2.3%
CLPTClearPoint Neuro, Inc.LTM Mar 2026$5.77M USD+897.9%—14.2%
AVNSAvanos Medical, Inc.LTM Mar 2026$4.9M USD+151.0%-74.3%0.7%
AKBAAkebia Therapeutics, Inc.LTM Mar 2026$2.48M USD-163.4%+27.1%1.1%
CMPSCOMPASS Pathways plcLTM Mar 2026$1.81M USD+305.3%-6.6%—
SIBNSI-BONE, Inc.LTM Mar 2026$617K USD-239.6%—0.3%
LABStandard BioTools Inc.LTM Mar 2026$571K USD-82.0%—0.7%
CTKBCytek Biosciences, Inc.LTM Mar 2026$428K USD-82.0%-37.8%0.2%
SNDLSNDL Inc.LTM Mar 2026CA$0 CAD——0.0%
Peer median (excluding CLPT) —+34.5%-19.3%0.7%

Competitors are the stored peer set for CLPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(14.41M)(16.43M)(22.09M)(18.91M)(25.54M)
Depreciation & Amortization692K777K1.51M1.9M982K
Deferred Income Tax202K0000
Stock-Based Compensation2.08M4.13M6.08M6.91M8.18M
Change in Working Capital(1.68M)(4.29M)(1.4M)1.4M(9.81M)
Accounts Receivables627K(211K)(1.8M)(1.21M)(268K)
Inventory(1.71M)(4.42M)1.25M743K(103K)
Accounts Payables(762K)1.59M03.11M(7.52M)
Other Working Capital165K(1.25M)(846K)(1.24M)(1.92M)
Other Non-Cash Items425K3.78M2.18M(245K)2.27M
Operating Cash Flow(12.7M)(16.17M)(13.72M)(8.95M)(23.93M)
Capital Expenditures(168K)(253K)(717K)(275K)(522K)
Acquisitions (Net)00001.14M
Purchases of Investments0(21.59M)000
Sales of Investments012M000
Other Investing Activities009.67M00
Investing Cash Flow(168K)(10.74M)8.95M(275K)615K
Debt Repayment000(10M)48.09M
Common Stock Issued46.79M745K016.15M3.95M
Common Stock Repurchased00(210K)00
Dividends Paid00000
Other Financing Activities90K(336K)506K40K(1.86M)
Financing Cash Flow46.88M409K296K6.19M50.18M
Effect of Forex Changes00000
Net Change in Cash34.01M(26.49M)(4.48M)(3.04M)26.87M
Free Cash Flow(12.87M)(16.42M)(14.44M)(9.23M)(24.45M)

ClearPoint Neuro, Inc.

NASDAQ:CLPT

Intrinsic Alpha fair value

Locked

Current Price

$7.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.